Sorrento Therapeutics, Inc. (SRNE) News Headlines

▮ More

Date

Headline

1/22/2019 7:07:19 AM Sorrento Therapeutics Announces Interim Results In Osteoarthritis Knee Pain Phase 1b Trial Of Resiniferatoxin

1/14/2019 7:09:42 AM Scilex Reports Addition Of ZTlido To Express Scripts National Formularies

11/1/2018 7:24:54 AM Sorrento Therapeutics Begins Dosing In Anti-CD38 CAR-T Phase 1 Clinical Study For R/r Multiple Myeloma

9/10/2018 8:59:48 PM Delcath Gets Focus, PRQR Keeps Hitting New Highs, ECYT Turning Heads

9/10/2018 4:01:37 AM Sorrento Therapeutics Subsidiary, Scilex, Raises $140 Mln In Non-Dilutive Royalty-Based Financing

8/13/2018 4:01:56 AM Sorrento Therapeutics Says Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety And Efficacy Expectations

7/3/2018 9:31:58 AM Sorrento Therapeutics Acquires Sofusa Lymphatic Delivery Platform For Immune-Oncology Antibody Therapeutics

6/26/2018 9:50:59 PM SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz

4/16/2018 8:59:50 PM APVO Walks The Talk, Eleven Bio Gains Over 13%, PADDOCK Data Boosts APLS

3/28/2018 9:34:11 PM Sorrento Therapeutics CEO Says Confident Of Executing Strategic Plan

3/27/2018 8:06:08 AM Sorrento Therapeutics Announces Unsecured $120.5 Mln Convertible Note Financing

3/19/2018 8:14:21 AM Sorrento Therapeutics Appoints Jiong Shao As EVP And CFO

3/5/2018 9:22:13 AM New Drugs Approved In February

2/28/2018 8:50:59 PM ECYT Has VISION, LPCN Up 50% In 5 Days, MYO On Watch, FDA Nod Boosts SRNE

2/24/2018 11:34:41 PM An Ear To The Pharma: 6 Stocks To Watch This Week

1/25/2018 10:33:36 PM Biotech Stocks Facing FDA Decision In February

1/24/2018 8:16:28 AM Sorrento Therapeutics Announces Expansion Of Its GMP CAR-T Manufacturing Capacity

12/22/2015 8:34:03 AM FBR Capital Markets Initiates Sorrento Therapeutics, Inc. (SRNE) At Outperform With $22 Price Target

Older Articles